Real Research

Real Research

Warsaw, Poland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Real Research is a Warsaw-based biotech firm leveraging artificial intelligence and novel laboratory techniques to modernize biomedical research. Its dual focus includes an AI-driven platform aimed at streamlining clinical trials and a proprietary 3D cell culture product, LifeGel, designed to improve biological modeling. Founded in 2018, the company is a private, likely pre-revenue entity targeting the digital health and advanced research tools markets. Its strategy combines software-as-a-service potential with tangible research consumables.

Digital HealthAI / Machine Learning

Technology Platform

AI/ML platform for clinical trial optimization and patient recruitment; LifeGel hydrogel for 3D cell culture.

Opportunities

The company addresses two large, growing markets: clinical trial inefficiencies and the demand for advanced 3D cell culture models.
Success in either area could generate significant value.
The Polish/EU location provides access to grant funding and technical talent at a competitive cost.

Risk Factors

Managing two distinct technology development tracks (software AI and biomaterials) risks diluting focus and resources for a small startup.
Both target markets are highly competitive with established players, posing a significant market adoption challenge.

Competitive Landscape

In clinical trial tech, competitors range from large CROs with digital arms to pure-play SaaS companies. In 3D cell culture, competition includes global life science tools giants (e.g., Corning) and numerous specialized biotech startups. Real Research must demonstrate clear differentiation in performance, cost, or ease of use.